UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.315

Sortiert nach

Religious Othering: Global Dimensions

1st, 2023

Link zum Volltext

Verfügbarkeit prüfen

Humpback whale populations share a core skin bacterial community: towards a health index for marine mammals?

PloS one, 2014-03, Vol.9 (3), p.e90785

2014

Link zum Volltext

Verfügbarkeit prüfen

Antibody-Drug Conjugate-Based Therapeutics: State of the Science

JNCI : Journal of the National Cancer Institute, 2019-06, Vol.111 (6), p.538-549

2019

Link zum Volltext

Verfügbarkeit prüfen

PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline

Journal of clinical oncology, 2020-10, Vol.38 (30), p.3468-3493

2020

Link zum Volltext

Verfügbarkeit prüfen

PARP inhibitor associated treatment related myeloid neoplasms: What was a “Rare” complication may be less so

Gynecologic oncology, 2021-06, Vol.161 (3), p.639-641

Moore, Kathleen N.

2021

Link zum Volltext

Verfügbarkeit prüfen

An assessment of temporal, spatial and taxonomic trends in harmful algal toxin exposure in stranded marine mammals from the U.S. New England coast

PloS one, 2021-01, Vol.16 (1), p.e0243570

2021

Link zum Volltext

Verfügbarkeit prüfen

The Use of Likert Scales With Children

Journal of pediatric psychology, 2014-04, Vol.39 (3), p.369-379

2014

Link zum Volltext

Verfügbarkeit prüfen

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

The lancet oncology, 2019-05, Vol.20 (5), p.636-648

2019

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

Journal of clinical oncology, 2019-11, Vol.37 (31), p.2825-2834

2019

Link zum Volltext

Verfügbarkeit prüfen

Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study

Journal of clinical oncology, 2017-04, Vol.35 (10), p.1112-1118

2017

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline

Journal of clinical oncology, 2016-10, Vol.34 (28), p.3460-3473

2016

Link zum Volltext

Verfügbarkeit prüfen

First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors

Journal of clinical oncology, 2020-06, Vol.38 (16), p.1824-1835

2020

Link zum Volltext

Verfügbarkeit prüfen

Trials in progress: IMagyn050/GOG 3015/ENGOT-OV39. A Phase III, multicenter, randomized study of atezolizumab versus placebo administered in combination with paclitaxel, carboplatin, and bevacizumab to patients with newly-diagnosed stage III or stage IV ovarian, fallopian tube, or primary peritoneal cancer

International journal of gynecological cancer, 2019-02, Vol.29 (2), p.430-433

2019

Link zum Volltext

Verfügbarkeit prüfen

The poly (ADP ribose) polymerase inhibitor niraparib: Management of toxicities

Gynecologic oncology, 2018-04, Vol.149 (1), p.214-220

2018

Link zum Volltext

Verfügbarkeit prüfen

COVID‐19 distress and worries: The role of attitudes, social support, and positive coping during social isolation

Psychology and psychotherapy, 2021-06, Vol.94 (2), p.365-370

2021

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline

Gynecologic oncology, 2016-10, Vol.143 (1), p.3-15

2016

Link zum Volltext

Verfügbarkeit prüfen

Poly(ADP-Ribose) Polymerase Inhibitor Inhibition in Ovarian Cancer: A Comprehensive Review

The cancer journal (Sudbury, Mass.), 2021-11, Vol.27 (6), p.432

2021

Link zum Volltext

Verfügbarkeit prüfen

Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial

Journal of clinical oncology, 2023-01, Vol.41 (3), p.609-617

2023

Link zum Volltext

Verfügbarkeit prüfen

Psychological flexibility: positive implications for mental health and life satisfaction

Health promotion international, 2020-04, Vol.35 (2), p.312-320

2020

Link zum Volltext

Verfügbarkeit prüfen

Patient Counseling and Management of Symptoms During Olaparib Therapy for Recurrent Ovarian Cancer

The oncologist (Dayton, Ohio), 2016-08, Vol.21 (8), p.954-963

2016

Link zum Volltext

Verfügbarkeit prüfen

Testing for High-Risk Human Papillomavirus in Lower Genital Tract Tumors: If Knowledge Does Not Translate to an Action That Helps Patients-Why Do It?

Journal of clinical oncology, 2022-05, Vol.40 (14), p.1514-1517

2022

Link zum Volltext

Verfügbarkeit prüfen

Lists and Lotteries: Rationing in the Housing Choice Voucher Program

Housing policy debate, 2016-05, Vol.26 (3), p.474-487

Kathleen Moore, M.

2016

Link zum Volltext

Verfügbarkeit prüfen

Google Haul Out: Earth Observation Imagery and Digital Aerial Surveys in Coastal Wildlife Management and Abundance Estimation

Bioscience, 2017-08, Vol.67 (8), p.760-768

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.315

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.958)
Mit Volltextzugriff
(2.001)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(144)
Gynecologic Oncology
(141)
International Journal Of Gynecological Cancer
(39)
Pediatrics
(27)
Cancer Research
(25)
Plos One
(24)
The New England Journal Of Medicine
(23)
Blood
(17)
Science
(16)
Diabetes Care
(15)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(24)

Menü

Weitere Dienste

Einstellungen

Religious Othering: Global Dimensions

Humpback whale populations share a core skin bacterial community: towards a health index for marine mammals?

Antibody-Drug Conjugate-Based Therapeutics: State of the Science

PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline

PARP inhibitor associated treatment related myeloid neoplasms: What was a “Rare” complication may be less so

An assessment of temporal, spatial and taxonomic trends in harmful algal toxin exposure in stranded marine mammals from the U.S. New England coast

The Use of Likert Scales With Children

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)

Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline

First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors

Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial

The poly (ADP ribose) polymerase inhibitor niraparib: Management of toxicities

COVID‐19 distress and worries: The role of attitudes, social support, and positive coping during social isolation

Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline

Poly(ADP-Ribose) Polymerase Inhibitor Inhibition in Ovarian Cancer: A Comprehensive Review

Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial

Psychological flexibility: positive implications for mental health and life satisfaction

Patient Counseling and Management of Symptoms During Olaparib Therapy for Recurrent Ovarian Cancer

Testing for High-Risk Human Papillomavirus in Lower Genital Tract Tumors: If Knowledge Does Not Translate to an Action That Helps Patients-Why Do It?

Lists and Lotteries: Rationing in the Housing Choice Voucher Program

Google Haul Out: Earth Observation Imagery and Digital Aerial Surveys in Coastal Wildlife Management and Abundance Estimation

Suchergebnisse filtern